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FRAMING HEALTH MATTERS

Detecting, Preventing, and Treating Sexually
Transmitted Diseases Among Adolescent Arrestees:
An Unmet Public Health Need
Steven Belenko, PhD, Richard Dembo, PhD, Matthew Rollie, MPH, Kristina Childs, MA, and Christopher Salvatore, MA

Studies of detained and incarcerated adolescent offenders in the United States
indicate that these juveniles have an elevated risk of sexually transmitted
diseases (STDs). However, many more arrestees enter the ‘‘front end’’ of the
juvenile justice system than are detained or incarcerated, and research into the
STD risk profiles and service needs of this larger group is lacking. An expansion
of STD testing (including of asymptomatic youths), prevention, and treatment is
needed, as is improved knowledge about gender- and race-specific services. A
pilot program in Florida has shown that juvenile justice and public health
systems can collaborate to implement STD testing among new arrestees. With
integrated linkages to treatment and prevention after release, this model could
greatly reduce the STD burden in this underserved, high-risk population. (Am J
Public Health. 2009;99:1032–1041. doi:10.2105/AJPH.2007.122937)
Adolescents in the US juvenile justice system
have relatively high rates of health problems,1–3
including elevated risks of the sexually transmitted diseases (STDs) chlamydia (Chlamydia
trachomatis) and gonorrhea (Neisseria gonorrhoeae). Detained and incarcerated adolescent
offenders, in particular, have high rates of STDs
that make them a potentially important core
subgroup of STD transmitters.4–8 However, the
STD risks and service needs of adolescent offenders before detention or incarceration (the
largest adolescent offender population) or the
organizational factors that limit access and service linkages for this population have been little
discussed. Although most arrested youths
quickly return to the community, we are unaware of any STD screening protocols at the
initial stage of arrest. Models of STD transmission dynamics9,10 suggest that reducing or
preventing infections in core risk groups, such as
in juvenile arrestees, can further reduce transmission in the community.11
A critical need exists to expand STD surveillance among young arrestees before detention or incarceration. Studies of the prevalence of STDs and their drug- and sex-related
risk behaviors indicate a high risk of STDs
among detained or incarcerated youths. However, numerous organizational and structural
barriers and policy and implementation issues

limit the expansion of STD testing and treatment at the initial stages of the juvenile justice
process. Nevertheless, a promising voluntary
STD testing and treatment program for newly
arrested juveniles illustrates a collaborative
partnership between the public health and
juvenile justice systems that overcomes these
barriers. This model provides immediate access
to STD services for this high-risk and underserved population. (For ease of expression, we
use the term nonincarcerated throughout to
refer to youths who are in the community and
are not in secure custody, whether detained
pending adjudication or incarcerated after a
finding of guilt).

THE JUVENILE JUSTICE SYSTEM
The juvenile justice system focuses primarily
on public safety; it is neither organized to routinely identify or treat infectious diseases nor
oriented toward increasing access to preventive
health care.3,12 The following is a basic description of how juvenile arrests (2.1 million in 2005,
including all arrests of persons under age 18
years13) are processed, illustrating how most offenders are released from custody early in the
process rather than being detained or incarcerated.
The first juvenile justice system stage after
arrest is intake. At this time, juvenile
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probation officers can dismiss the case, process it informally (e.g., warning the youth or
calling parents), or bring the case before a
judge.14–16 In some jurisdictions, centralized intake facilities such as juvenile assessment centers
perform this function.17 Most delinquency cases
(57%) are formally convicted in juvenile court;
the remainder are dismissed, diverted to community programs, or processed informally.18 For
nondiverted adolescent offenders, a prosecutor
decides whether to detain the youth in a secure
facility before adjudication; only 20% of these
youths are detained.14,15
Convicted youths may be placed on juvenile
probation (62%) or, in more serious cases,
placed in a secure residential facility. Probation
conditions may include a curfew, attending
school, or participating in drug treatment or
other services.14–16 Some convicted youths are
incarcerated in residential facilities (with a range
of security levels), with some health care services
available.16 At discharge, youths are typically
placed on 3 to 12 months of aftercare supervision19; this includes counseling, education, electronic monitoring, treatment, or community
service referrals.14 Juveniles violating aftercare
conditions can have their aftercare status revoked
and be returned to a secure institution.14 Although, in principal, youths placed in the custody
of juvenile justice agencies receive a medical
evaluation and indicated care, the scope and
quality of this care varies considerably.1,20–22

REASONS FOR SCREENING
ADOLESCENT ARRESTEES
The strongest reasons for expanding STD
services among juvenile arrestees include
the high rates of STDs and drug and sex
risk behaviors among young offenders, the
asymptomatic nature of many chlamydia and
gonorrhea infections, and the fact that most
arrested youths are not detained or incarcerated.
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In the United States, chlamydia and gonorrhea rates continue to be highest among adolescents and young adults in the general population. In 2006 the highest age-specific rate
of reported gonorrhea cases in women was
among adolescents aged 15–19 years (648 per
100 000); for men the highest rate was among
those aged 20–24 years (454 per 100 000).23
The highest age-specific rates of reported chlamydia cases were found among the same
groups of adolescent girls (2862 cases per
100 000) and men (857 per 100 000).23 An
estimated 60% of annual incident gonorrhea
and 54% of incident chlamydia cases are among
youths and young adults aged 15–24 years.24
A recent national study of chlamydia prevalence
found that 4.6% of adolescent girls aged 14–
19 years were infected, the highest proportion of
any age group.25 Among young women aged
16–24 years entering the National Job Training

Program (which targets high-risk, low-income
youths), the median chlamydia prevalence within
states was 13.1% (range 4.9% to 20.0%);
among adolescent boys, the median chlamydia
prevalence was 7.9% (range 1.8% to 12.4%).23
Young offenders are at even higher risk.
Two decades ago, Bell et al. suggested that
‘‘adolescent detainees may be disproportionately important as core-group transmitters of
STD.’’26(p33) Several subsequent studies of
detained and incarcerated adolescents established a high STD prevalence in this population
(Table 1). Among incarcerated or detained adolescent boys, chlamydia positivity ranged from 5.9%
to 14.4% and gonorrhea positivity from 0.6% to
6.7%. For adolescent girls, the percentage positive
for chlamydia ranged from 9.5% to 32.5% and
that for gonorrhea from 5.1% to 23.4%.
Several studies also have found high STD
prevalence among nonincarcerated offenders.

One comparison between incarcerated youths
and those in alternative facilities in Washington, DC, found positive test rates of 9.2% for
both chlamydia and gonorrhea, with most
cases in the alternative setting; the authors
suggested screening and treatment when
youths enter the system.34 A study of African
American adolescents in Atlanta, Georgia (average age 18.5 years), compared self-reported
STD diagnosis (chlamydia, gonorrhea, or trichomoniasis) for those with or without a history of
conviction.35 Lifetime history of an STD was
much higher for convicted adolescents (31.6%
vs 16.2%), and current STD infection was
about 3 times higher (10.1% vs 3.2%). In Hillsborough County in Tampa, Florida, we found
a high percentage of STDs among newly
arrested youths aged 12–18 years entering the
county’s juvenile assessment center. Overall,
19.2% of adolescent girls and 10.5% of

TABLE 1—Review of Studies of Chlamydia and Gonorrhea Diagnoses Among US Adolescent Offenders
Authors
Bell et al. (1985)26
Broussard et al. (2002)27
Canterbury et al. (1995)4

Period

Gender

% Positive
for Chlamydia

% Positive
for Gonorrhea

King County, WA

1981

Female

19.8

18.4

Cook County, IL

1998–1999

Male

12.9

4.3

Female

32.5

13.6

Male

8.6

0.6

Sample

Location

Detainees, new admissions (N = 100)
Detainees, processed (N = 5558)
Detainees, intake

Unknown state

NA

Female

9.5

5.4

Detainees in 14 detention

Alameda County, CA;

1997–2002

Male

5.9

1.3

centers, cross-sectional

Los Angeles, CA;

records (N = 1215)
Kahn et al. (2005)5

sample (N = 131,915

San Francisco, CA;

chlamydia and 71 074

Atlanta, GA; Maryland;

gonorrhea tests)

New York, NY
Female

15.6

5.1

Katz et al. (2004)28

Detainees, admissions on selected
screening dates (N = 101)

Hawaii

2000–2001

Female

13.9

5.9

Lofy et al. (2006)29

Detainees, 4 detention centers (N = 3593)

Washington

1998–2002

Female

13.7

NA

Detainees (N = 98)

Seattle, WA

NA

Male

10.9

5.5

Detainees, consecutive

Jefferson County, AL

1996–1997

Male

8.8

2.8

O’Brien et al. (1988)30
Oh et al. (1998)7

admissions (N = 263)
Female

28.3

13.1

Pack et al. (2000)31

Detainees, consecutive admissions (N = 284)

Birmingham, AL

May–November 1997

Male

14.4

6.7

Risser et al. (2001)8

Detainees, consecutive admissions (N = 589)

Harris County, TX

June–August 1998
January–May 1999

Male
Female

9.6
28.1

6.7
23.4

Detainees (N = 763)

Unknown southern city

2002-2003

1.5

Robertson et al. (2005)32
Shafer et al. (1993)33

Detainees (N = 269)

NA

NA

Male

8.1

Female

24.7

7.3

Male

10.7

6.6

Note. NA = not available.
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adolescent boys tested positive for chlamydia,
gonorrhea, or both. The highest prevalence was
among African Americans (26.9% among adolescent girls, 15.4% among adolescent boys),
Hispanic girls (25.0%), and those aged 15–18
years (22.1% among adolescent girls, 12.8%
among adolescent boys).36
Given these high STD risk levels, and because most arrestees are never detained or
incarcerated,15 increased testing is needed before detention or incarceration. Moreover, such
screening should not be symptom based, because
most of these infections are asymptomatic.37,38
One study found that 77% of female adolescents
in Baltimore, Maryland, with chlamydia and
45% with gonorrhea were asymptomatic.39
Young male detainees in Birmingham, Alabama,
had low rates of urogenital symptoms while
testing positive for gonorrhea (9.8%), chlamydia
(2.3%),4 or either disease (13.7%).31 Moreover,
most adolescent offenders currently are never
detained or leave detention quickly before any
testing is done. In the few facilities that offer
routine STD screening, specimens may be collected 2 to 7 days after intake, by which time
many adolescents are released. The elevated
STD rates for this population and asymptomatic
nature of these diseases increase the urgency of
expanding STD testing and treatment to the
largest possible segment of the juvenile justice
population.

SUBSTANCE USE, SEX, AND OTHER
RISK FACTORS
Drug and alcohol use, risky sexual behaviors,
and other risk factors are common among
adolescent offenders, which increases the likelihood of contracting STDs, indicating a need
for expansion of risk reduction and substance
abuse prevention and treatment services for
these youths.

Drug and Alcohol Use
An estimated 35% of a national sample of
arrested adolescents had alcohol involvement,
(were using alcohol at the time of arrest or
reported alcohol-related problems) 70% had
drug involvement (were using drugs at the time
of arrest or reported drug-related problems),
and 75% had either drug or alcohol involvement.40 In 9 US jurisdictions in 2003, from
42% to 55% of adolescent boys tested positive

for an illegal drug, as did 26% to 65% of
adolescent girls.41 The incidence and prevalence
of both substance use42,43 and sex risk behaviors
increase with age, making it important to intervene early with substance abuse and health
promotion interventions.44 Because of the elevated infection risk associated with substance use,
improved treatment access can have an indirect
effect on infection dissemination. Limited access
to drug treatment for adolescent offenders45
increases the likelihood of their continued drug
use and escalation to more severe drug involvement and related risk behaviors.46

Risky Sexual Behaviors
The confluence of high-risk sexual and drug
use behaviors places adolescent offenders at
elevated STD risk.33 Canterbury et al. found
that 76% of incarcerated adolescents in 1 state
reported having 3 or more sexual partners.4 In a
survey of youths in 39 US juvenile detention
facilities, the adjusted risk of having an STD
history was 2.3 times higher for those with 2 to
10 sexual partners, 1.9 times greater for those
with a history of sexual abuse, and 1.8 times
greater for those with a history of alcohol use.2
Only 25% of female detainees and 32% of male
detainees reported condom use at last intercourse.
Compared with high school youths, detained
male offenders had a higher rate of sexual intercourse, double the STD incidence rate, and a
lower rate of condom use at last sexual intercourse.33 Among detained youths in a Southern
city, 62% consistently used condoms, yet 20%
tested positive for either chlamydia or gonorrhea.47
STD risk among adolescent boys in detention is significantly increased by multiple sexual
partners and inconsistent condom use.33 High
rates of risk behaviors have been found among
detained juveniles in Cook County, Illinois: 61%
of detained adolescent boys had had more than
1 partner in the past 3 months, 35% of adolescent boys and 41% of adolescent girls had had
recent unprotected vaginal sexual intercourse,
and 68% of adolescent boys and 52% of adolescent girls reported having had sexual intercourse while high.48 Finally, adolescents in
Atlanta with a conviction were significantly more
likely to engage in risk sexual behaviors, including early sexual initiation, multiple sexual partners, sexual intercourse with an infected partner,
or use of drugs or alcohol during sexual intercourse, than were those never convicted.35
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Studies have found associations among substance use, risk sexual behaviors, and STDs
among adolescents.49–52 Youth Risk Behavior
Survey data indicate that alcohol-using adolescents are twice as likely, and drug-using adolescents 3 times as likely, to have had 4 or more
sexual partners in their lifetime than are those
who do not drink or use drugs.53 A recent study
among rural STD clinic patients in Pennsylvania
found higher infection rates for those with a
substance use disorder.54

Other Risk Factors
Drug-involved young offenders also have
high rates of physical health, mental health,
social, and family problems, which increase
STD risk.55–59 Only 6.4% of incarcerated
youths in Maryland had ‘‘excellent’’ or ‘‘good’’
health profiles (compared with 34.2% of adolescent boys in school).1 In addition, many adolescent offenders also have antisocial and
drug-involved peers,60,61 poor family functioning,40,62–64 and lower self-esteem and resilience.65–67 These factors increase high-risk
behaviors and reduce the effects of risk-reduction
interventions.

ORGANIZATIONAL AND
STRUCTURAL BARRIERS
Despite juvenile arrestees’ elevated risk of
chlamydia and gonorrhea, significant barriers
exist to implementing STD services for this highrisk group. These barriers must be understood
to more effectively expand interventions.

Health Care Access
Programs that address the health care needs
of adolescent offenders must take into account
that many of these youths come from poor,
minority, and socially disadvantaged communities and face significant challenges to accessing health care services, especially after
release into the community.3,12 Research into
the social and economic factors relating to adolescent health and health care access indicates
that lower social class is associated with poorer
health profiles, lower health literacy, and lack
of access to preventive and treatment services.20,68
In 2004, 8.5 million American youths younger
than 18 years old had no medical insurance;
African Americans and Hispanics were less
likely than were Whites to be insured.69

American Journal of Public Health | June 2009, Vol 99, No. 6

FRAMING HEALTH MATTERS

Low-income adolescents are 4 times as likely as
middle- or high-income youths to not have a
usual source of health care, and 7 times as likely
to have unmet medical needs20 despite eligibility
for Medicaid or the State Child Health Insurance
Program. Most racial/ethnic health care studies
have found disparities for African American and
Hispanic youths in primary care services.21 Given
the overrepresentation of racial/ethnic minorities
in the juvenile justice system, health care access is
a particularly problematic issue.
Impediments to implementing routine health
screening and referral and other public health
interventions in the juvenile justice system
include a lack of shared goals and philosophies
by the juvenile justice and public health systems, resource constraints, lack of information
sharing, mutual mistrust, organizational ‘‘inertia,’’ and separate funding and oversight
mechanisms. These systems must be willing to
innovate in order to overcome these barriers to
expanding and integrating health care access.
But public-sector treatment and other health
services can be slow to incorporate innovations
into daily practice.70–72 Research and theory on
innovation diffusion suggest several organizational, individual, and social factors that facilitate
or impede implementation of these innovations
in specific organizational settings or in collaborative efforts between systems.73–76 To create
policies that increase service access for young
offenders, it is important that policymakers understand how the factors just noted operate.
Coordination is needed among different providers (e.g., social services, medical facilities, and
treatment facilities) serving youths infected with
STDs.77–79

Barriers to Implementing Services for
Adolescent Offenders
Several barriers prevent linkage of adolescent offenders to STD services. Willingness to
be tested for STDs can be influenced by privacy and confidentiality concerns.80,81 A study
of beliefs about chlamydia among those aged 16
to 21 years found several obstacles to testing:
fearing disclosure that they had been tested,
discovering that they have an STD, and being
HIV-positive.80 These findings are consistent
with previous studies examining youths’ attitudes
toward STD screening.81
Structural and social barriers to STD treatment access include transportation problems,21,82

language barriers,20 low health literacy,83 lack of
knowledge about treatment or testing locations,84 lack of insurance,20 long clinic waiting
times,84 perceived discrimination and lack of
empathy on the part of health care staff,84
feelings of shame and stigma,84–86 use of urethral specimen collection methods,84 and inconvenient clinic hours.84 Distance from services
also affects access, and adolescent offenders often
lack transportation.87–89 Lack of STD knowledge also can serve as a barrier to seeking
treatment, particularly among adolescent African
American girls,84 which suggests that subpopulations within the juvenile population require
special attention.
Although more research is needed on the
STD prevention service needs of adolescent
offenders, especially new arrestees and those
under community supervision, many barriers
exist to implementing these interventions.
With relatively low levels of community and
school connectedness,40,90,91 adolescent offenders as a population are less influenced by
social norms supporting less risky drug and
sexual behaviors and may not be receptive to
normative peer- or school-based curricula.
Adolescent offenders also have elevated
school dropout and truancy rates and are
likely to be placed in alternative schools, thus
reducing their exposure to school-based interventions.92 Academic problems and low
school and community attachment are risk factors for delinquency and substance abuse40,93,94
A relative lack of social connectedness means
that for many high-risk adolescent offenders,
their best opportunity to be linked to health and
STD prevention services may be through the
juvenile justice system.
Incarcerated youths face additional challenges because the organizational culture of
correctional facilities may deemphasize health
care, and there is insensitivity to privacy and
confidentiality issues.95 Inmates in correctional
institutions have a legal right to the same standard of health care that is available in the community; however, the mandate for care operates
within a system where security takes priority over
health care.95,96 For juvenile detention and correctional facilities, short lengths of stay and restricted inmate movement also create barriers to
effective STD treatment and intervention.95,97
Finally, confidentiality concerns are often a barrier in juvenile justice system settings: privacy is
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extremely limited and disclosure of an STD to
correctional staff and other adolescents may place
the infected youth at risk of harm.95 These factors
suggest that STD services for offenders in the
community may face fewer challenges for establishing or improving linkages between the juvenile justice and public health systems.

POLICY AND IMPLEMENTATION
ISSUES
As discussed in the previous section, a need
exists for new and creative policies to promote
linkages between the juvenile justice and public
health systems, especially for newly arrested
youths diverted to the community, placed on
probation, or released from detention, correctional, or secure residential facilities.3, 12, 98 However, several policy and service implementation
issues must be overcome to achieve this goal.

Policy and Legal Barriers
Expansion of STD services in the juvenile
justice system is complicated by policy and
legal constraints. State and federal laws protect
the confidentiality of juvenile records and adolescent health information, which complicates
the exchange of information across agencies.
Responsibility for parental notification, partner notification, disclosure to health care providers, and mandatory infectious disease
reporting are roles with which juvenile justice
system personnel may be neither comfortable
nor familiar.
Despite its potential value for detecting
hidden STDs, broad testing protocols for new
arrestees can be difficult to implement. Concerns center on costs, legal constraints placed
on the amount of time available to process
arrested youths through intake facilities, and
the availability of laboratory or staff resources to collect and process biological
specimens. However, the recent availability
of noninvasive, highly accurate urine-based
nucleic acid amplification tests for chlamydia
and gonorrhea greatly facilitates testing access by eliminating the need for more intrusive and time-consuming urethral or vaginal
swabs.31,33,99 Because many admission protocols and community supervision requirements include regular urine screening tests
for illegal drugs, adding urine-based STD
screening is relatively easy to implement. Our
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recent experience in Hillsborough County,
Florida (discussed in the section, ‘‘A Promising Model’’), illustrates the potential for such a
screening model.

Gender- and Race-Specific Services
Higher rates of STDs and unique health
service needs among female and minority adolescent offenders raise particular issues for
expanding STD-related services.
Female adolescent offenders. As male arrest
rates have decreased,15 adolescent girls have
become a growing proportion of the juvenile
justice population.15,100 In addition to a substantially higher likelihood of STDs, female
offenders have high rates of drug involvement
and more extensive health and social problems than do boys.100 Among detained female
adolescent offenders, 95% lacked a stable home
environment.101 Female adolescent offenders in
Los Angeles County were 3 times as likely as
other adolescent girls to have clinical depression
or anxiety symptoms.102 Female juvenile detainees in Cook County, Illinois, had significantly
higher rates of anxiety (31% of adolescent girls vs
21% of adolescent boys) or affective disorders
(28% vs 19%, respectively).103 Other studies
found high rates of sexual victimization104 and
physical abuse105 among young female offenders, both of which are associated with mental
health problems,106 substance abuse,107 and
risky sexual behaviors.108–110 Adolescent girls
who abuse substances have been found to
have higher rates of posttraumatic stress disorder than adolescent boys who abuse substances.65,111 More generally, urban, poor, and
minority women have relatively high risks of
STDs112 but lower rates of condom use.113 The
high levels of drug use, STD risk, and health
and social problems among female adolescent
offenders suggest a need to disseminate
knowledge about STDs and risk behaviors
and to develop gender-specific interventions.
Screening adolescent girls in detention facilities for chlamydia was designated a key performance measure under the Centers for
Disease Control and Prevention’s 2005
Comprehensive STD Prevention Systems
program announcement.114
Early STD detection and treatment is also
important to prevent other chronic, long-term
health sequelae, especially pelvic inflammatory
disease.86 Adolescent girls have the highest

age-specific rates of pelvic inflammatory disease
among sexually active females,23 and between
one fourth to three fourths of young women with
acute pelvic inflammatory disease have been
found to have chlamydia or gonorrhea.115 Delay
in the diagnosis and treatment of chlamydia or
gonorrhea is a major risk factor for pelvic inflammatory disease.116
Racial/ethnic minorities. National data indicate that African Americans and Hispanics are
at elevated risk of HIV and other STDs117–120;
these populations are disproportionately represented among adolescent offenders.100 Although
only 12% of the population, African Americans
accounted for 49% of new HIV/AIDS diagnoses
in the United States in 2004.117 Between 1999
and 2004, 47% of newly diagnosed HIV cases in
29 US states involved non-Hispanic Black
women.118 African Americans also are at high
risk of gonorrhea, with a rate 18 times greater
than that in Whites in 2006.117 Overall, the
prevalences of chlamydia and gonorrhea are
highest in African Americans in US juvenile
detention centers.5
These data suggest an urgent need to expand culturally specific risk reduction interventions for minority adolescent offenders.
Recent meta-analyses of behavioral interventions for African Americans and Hispanics
suggest that these interventions can reduce
risk behaviors and incident STDs.119–121 Few
of the reviewed studies, however, included
adolescents, and none involved adolescent
offenders.

Expanding Surveillance and
Prevention
Given the increased HIV infection risk for
STD-positive youths, the Centers for Disease
Control and Prevention has recommended HIV
prevention through early detection and
screening of other STDs, calling for (1) ‘‘establishing STD screening in non-medical settings
where persons at high risk for HIV and curable
STDs are encountered’’ and (2) ‘‘expanding
screening based on prevalence of infections
detected in pilot screening efforts.’’122(p11)
It is estimated that only one third of incident
STD infections are identified each year; accordingly, routine screening at the front end of
the juvenile justice system can identify many
undetected and untreated infections.39,87,123
Similarly, STD prevention and education services
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should be expanded through collaborations between the public health and juvenile justice
systems. Because most newly arrested youths
spend less than 24 hours in custody before being
released back into the community,15 front-end
prevention services need to be fairly brief and
implemented within a few hours of arrest. Data
from recent trials of brief computer-assisted
risk-reduction interventions for adolescents124,125 are encouraging and offer a promising model. Research on brief interventions
for other risky health behaviors (e.g., drug and
alcohol use) indicates that brief, theoretically
driven behavioral change interventions can be
effective.126,127 However, brief, educational,
nonskills-based classes are not likely to reduce
STD risk.128 We recognize that such brief
interventions cannot address the multiple health
needs of this population, but protocols for
new arrestees could be designed to facilitate
linkages to more extensive services later in the
process.
Several studies have found that adolescent
HIV/STD risk-reduction interventions can reduce risky sexual behaviors among other highrisk populations,129 including adolescents in
residential drug treatment,52 HIV-positive
youths,130 high-risk students,92 low-income
African American middle school students,131 and
adolescent African American girls.132 However,
few of these interventions have been tested
among adolescent offenders.22 In a review of 15
randomized clinical trials of HIV risk reduction
interventions, 10 studies found positive effects on
condom use. No significant effects on risky sexual
behaviors were found in the 4 studies targeting
adolescent offender or incarcerated populations.133
Finally, the importance of implementing
broader routine testing and treatment of chlamydia and gonorrhea for young arrestees is
driven by STD transmission dynamics. STD
transmission involves a circular pattern of
sexual exposure to an infected person, acquisition of infection, and transmission of the
infection to a susceptible partner. Sustained
prevention efforts during this cycle can drive
an infection toward extinction in the entire
population, especially when these interventions
focus on the core groups with the highest
transmission rates.9,10
Expanded STD screening and related services must be sensitive to the special needs of
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female and minority youths and should make
use of urine-based testing, perhaps those linked
to extant drug-testing protocols.

A PROMISING MODEL
To address STD surveillance and service
gaps, new models of collaborations between
the juvenile justice and public health systems
are needed to increase STD screening for new
arrestees, the largest group of young offenders.
Between June and December 2006, we
implemented a successful pilot collaborative
effort involving the Hillsborough County,
Florida, Juvenile Assessment Center (HJAC; a
centralized intake facility for arrested juveniles), the Florida Department of Health Bureau of Laboratories, Tampa Branch (DOH),
the Hillsborough County Health Department
(HCHD), and the Florida Department of Juvenile Justice. The protocol involved 3 key steps:
(1) HJAC assessors were trained to provide
brief STD precounseling to newly arrested
juveniles, (2) HJAC assessors asked arrested
juveniles to voluntarily provide a urine sample
for drug testing (part of existing standard protocol) and to voluntarily consent to having their
urine specimen split and tested for chlamydia
and gonorrhea, and (3) communication and
coordination were established among HJAC
staff, DOH staff, and HCHD disease intervention specialists to facilitate treatment for infected youths. Youths processed through the
HJAC received a full assessment that was used
for discharge placement planning. About 60%
of all arrested youths processed through the
HJAC agreed to be assessed.
The planning process benefited from R. D.’s
established relationships with HJAC administrators and community agencies, long-term
experience with HJAC operations, and experience with the HCHD on a previous pilot
STD-testing project. These relationships and
support among community and government
stakeholders (including the County Sheriff’s
Office and the Department of Juvenile Justice)
facilitated implementation. Providing access to
free HCHD treatment for STD-positive youths
was a critical factor in achieving community
stakeholder buy-in and overcoming typical
barriers to interagency collaborative efforts in
the juvenile justice system. Project planning
involved a series of meetings with key agency

stakeholders aimed at establishing an efficient
and effective flow of information that also
maintained confidentiality. We successfully
pilot-tested the protocol in May 2006 and it
was fully implemented on June 16, 2006. A
brief summary of the procedures follows.
To comply with the requirements of the
Department of Health and Human Services
Office for Human Research Protections and the
project institutional review boards, project research staff could not have direct contact
with the youths. In addition, Florida state law
protects the confidentiality of youths 12
years and older who are tested for STDs, even
from their parents, and parental consent for
an STD test is not required. After receiving
human subjects certification from the National
Institutes of Health, HJAC staff were trained by
us to (1) conduct STD pretest counseling of
eligible youths, (2) obtain consent to split the
youths’ urine specimens for STD testing, (3)
complete a supplemental contact form on consenting youths (to assist HCHD Disease Intervention Specialists in locating infected youths
for treatment), and (4) administer a supplemental risk behavior assessment. In addition to
the Office for Human Research Protections
approval, all recruitment and consent procedures were reviewed and approved by the
relevant institutional review boards.
Eligible youths were those 12 years and
older, arrested for a delinquent offense, who
consented to giving a urine sample for drug
testing. A separate consent was given to have
the urine sample split at the DOH and tested for
chlamydia and gonorrhea. The recruitment
period was extended for adolescent girls to
obtain a roughly equal number of participants
of each gender. The HJAC assessed 1393
youths between June 16 and December 31,
2006, of whom 83% agreed to provide a urine
specimen for drug testing; 86.5% of these
additionally agreed to the STD testing. Overall,
72% of all screened youths agreed to the STD
testing, which indicates the feasibility of frontend STD testing. No significant gender or race
differences were found in STD test consent
rates (adolescent girls, 72.7%; adolescent boys,
70.5%. Whites: 71.6%; African Americans,
71.8%; Hispanics, 69.6%).
The STD pretest counseling protocol was
developed in consultation with the HCHD and
the DOH and included the following topics: (1)
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getting tested for chlamydia or gonorrhea is
very important; (2) these diseases are spread
through unprotected sexual intercourse or
during birth; (3) the urine specimen already
provided for drug testing can also be tested for
chlamydia and gonorrhea; (4) the test requires
written permission and is completely voluntary; (5) the test is strictly confidential—the
youth’s family, school, judge, or probation officer will not be informed of the test results; and
(6) if the test is positive, the HCHD will contact
the youth personally and confidentially to
provide free treatment with antibiotics. All
youths, whether or not they consented to the
STD test, were also given written DOH materials with information about protecting themselves from STDs, getting tested, and finding
out more about STDs. Posttest counseling was
given by the Disease Intervention Specialists at
the time of treatment follow-up.
STD testing used the FDA-approved nucleic
acid amplification test (Aptima Combo 2, GenProbe, San Diego, CA).99 A DOH technician
transferred urine from the drug specimen cup
to a Gen-Probe urine collection vial via pipette,
per Gen-Probe protocol. The vial was taken to
an in-house Gen-Probe testing machine for
analysis. Batch analyses were performed 2 to 3
times per week, with an approximate 48-hour
turnaround time from specimen collection to
test results. Testing costs were $15 per screen
for the 2 diseases.
For STD-positive youths, supplemental contact and STD test result forms were sent immediately by secure fax to HCHD Disease
Intervention Specialists for follow-up contact
and treatment that conformed with standard
HCHD protocols for chlamydia and gonorrhea
infections. Disease Intervention Specialists are
required to clear STD-positive cases (e.g., treated,
refused treatment, or unable to locate) within
14 days of detection, although most cases were
cleared within 7 days. Upon contact, STDpositive youths in the community usually
traveled on their own to the main HCHD clinic
in downtown Tampa for treatment. For about
25% of the STD-positive cases, the Disease
Intervention Specialist drove the youth to the
clinic for treatment. For youths placed in one of
Hillsborough County’s 2 juvenile detention
centers, a Disease Intervention Specialists
would contact a designated person at each
detention center to determine whether the
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youth was still in custody. If so, the Disease
Intervention Specialist would coordinate with
the detention center’s contact person to arrange for on-site treatment.
Treated youths were also asked by the
HCHD Disease Intervention Specialists to provide a voluntary blood specimen to test for
syphilis and HIV. During our project, this
screening identified 1 HIV-infected youth and 3
youths with syphilis. STD-positive youths were
also asked to identify and refer their sexual
partners to the clinic for testing and treatment.
Overall, 62.1% of STD-positive youths were
treated (59.3% of cases among boys and
64.0% among girls). Among those in detention,
60% received treatment, compared with 69%
of those released to the community.6,38 Failure
to treat was the result of Disease Intervention
Specialists not being able to contact the youth;
only 1 youth refused treatment once contacted
by a Disease Intervention Specialist.

CONCLUSIONS
The value of early detection and routine
surveillance of infectious diseases for identifying high-risk populations and geographic
distributions of infections is well established.9,38,122,134 Adolescent offenders at all
stages of the juvenile justice system are at high
risk of STDs, yet screening mainly occurs in
detention or correctional facilities. Only a
small percentage of young offenders are ever
incarcerated or detained for any period of
time. Most are quickly released back into the
community after arrest, which suggests the
need for screening protocols at the front end
of the juvenile justice system. Public health
officials have called for systematic collection
of STD data in juvenile justice populations,
while also recognizing that many barriers exist
to developing and implementing such surveillance programs.11
Our analysis suggests an urgent public health
need to extend STD testing, prevention, and
treatment services to newly arrested young
offenders. Additional research is also needed
on (1) the epidemiology of STDs and risk
behavior patterns among all adolescent offenders; (2) STD prevention service gaps; (3)
strategies to facilitate access to testing, prevention, and treatment services; and (4) individual
and organizational barriers to implementing

broader disease surveillance and more effective gender- and race-specific STD services.
With many high-risk arrested youths processed
quickly through the system and released back
into the community,100 new data are needed
among the broadest possible segment of the
juvenile justice population.135
Our experience in Hillsborough County indicates that juvenile justice and public health
systems can collaborate to implement STD
surveillance among newly arrested youths and
that most of these youths will voluntarily agree
to urine-based STD testing. Based on the results of our project, the HCHD and HJAC
implemented, effective August 27, 2007, a
permanent, voluntary STD testing and treatment protocol for newly arrested youths processed through the HJAC. The HJAC serves a
similar population and operates in a manner
similar to other juvenile assessment centers
serving metropolitan areas around the United
States. Thus, our model may be transportable
to other jurisdictions.
Such front-end screening coupled with rapid
treatment linkages and expansion of effective
risk reduction interventions at subsequent
stages of juvenile justice system processing
could greatly reduce STD incidence and prevalence in the community.134 It is also likely to be
cost-effective.136 Although youths spend insufficient time in the arrest processing facility to
implement full-scale risk reduction interventions,
brief interventions (perhaps computerized)
should be developed and tested in arrest processing centers to provide information about
STDs and motivate arrested youths to seek
sexual and reproductive health care services after
their release back to the community. Improving
access to substance abuse treatment after leaving
the juvenile assessment center may also reduce
STD risk as well as improve health and social
functioning.46,137
Given the general health care needs of this
population, the need for improved linkages
between the juvenile justice and public health
systems, and a need for integrated continuum
of care as youths move through the juvenile
justice system, an effective STD screening process could also facilitate linkages to health care
by initiating the youths’ contact with the local
health department. Expanded STD surveillance
can improve resource allocations and more
targeted placement of STD prevention and
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treatment services.138 Collaborative models involving public health and juvenile justice systems, as well as public health and intervention
researchers, hold great promise for addressing
STD risks and treatment needs among high-risk
adolescent arrestees. j
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